Link Venture Capital
Link Venture Capital is a leading Nordic early-stage fund.
Across our funds we have 50+ investments, with 5 IPO to date.
We invest from pre-seed to A, with a strong preference of being first investor in.
Our investment thesis is "Energy transition" + "Software is eating the world" + "Sustainability". Within this thesis we are actively looking for startups in solar, battery, storage, EV, EV charging, mobility, autonomous mobility, aquaculture, cleantech and more.
We love speaking to early founders and can help structure any investment round with local and international investors.
Get in touch or register through our web site.
Link Ventures
Link Ventures is a venture capital firm based in Kendall Square, Cambridge, Massachusetts, founded in 2006. The firm focuses on investing in technical founders developing disruptive AI technologies. With a team of 12 professionals, Link Ventures partners closely with talent from MIT and Harvard to launch transformational startups through unparalleled access, incubation, and strategic support.
Link Ventures invests in sectors such as artificial intelligence, data science, enterprise, and consumer technologies. The firm typically invests in pre-seed to Series A stages, with check sizes ranging from $1 million to $8 million. Their investments are primarily in the United States, Canada, and Israel. Link Ventures also provides 40,000 square feet of incubator space and has a global network across six continents.
Notable portfolio companies include Blitzy - software development applications, CarGurus - automotive marketplace, Trust & Will - estate planning services, Liquid - financial software, and TripAdvisor - travel services.
Link-age
Link-age is a venture capital firm based in Mason, Ohio, founded in 2001. The firm is led by CEO Scott Collins, who has a background with GE Capital, and Executive VP Steve Wittman. The team consists of five members, including two partners. Link-age is distinguished by its focus on the aging population, leveraging over 150 years of combined industry experience to provide tailored solutions for senior living communities.
Link-age invests primarily in the healthcare sector, with a focus on HealthTech and Enterprise Applications. The firm participates in private equity and Series B rounds, primarily within the United States. They offer a concierge approach to sourcing products and services, maximizing savings and rebates for their member communities through collective purchasing power.
Notable investments by Link-age include Skilled Care Pharmacy - a provider of pharmaceutical services, and CivicHealth - a health technology company. These investments reflect their commitment to enhancing the quality of life for the aging population through strategic partnerships and innovative solutions.
Linley Capital (Ventures)
Linley Capital is a private investment firm based in New York. The firm focuses on mid-sized companies and has a global perspective, investing primarily in the United States, Europe, and Latin America. Linley Capital differentiates itself through a long-term and conservative investment strategy, working closely with management teams to develop sustainable growth strategies.
The firm invests in companies with revenues ranging from $100 million to $2 billion across various sectors, including industrial, technology, energy, e-commerce, financial, and consumer. Linley Capital engages in buyouts, recapitalizations, growth capital investments, and turnaround investments. They aim to support management teams by providing capital for expansion and operational improvements.
Notable investments include companies in the consumer, industrial, manufacturing, and software sectors. Linley Capital also has a specific focus on technology through its Linley Capital Technology Ventures initiative, which targets software and tech companies in e-commerce, sports, media, entertainment, and financial services.
Linn Grove Ventures
Established in 2007 as the ag tech market began to form, Linn Grove recognized early on that the technology rich business environment of the Midwest will continue to excel in the healthcare, agriculture, food and animal health markets. By founding early stage companies and co-investing with others, Linn Grove established a strong investment portfolio first in the medical field and then in agricultural technology. We are proud to participate in continuing our regions rich history of world-class companies and innovation.
<br />
Linnaeus Capital Partners B.V.
Linnaeus Capital Partners B.V. is a private investment company headquartered in Amsterdam, founded in 2009. The firm is led by joint directors Anna Terwey and Alejandro Mansilla Cruz. Anna brings over 20 years of experience in corporate management and legal coordination, while Alejandro has a background in consulting for major organizations at McKinsey and Company. Linnaeus sets itself apart with a commitment to developing a future vision for each company it invests in.
The firm's investment strategy includes a focus on diverse sectors and stages. Although specific sectors and check sizes are not detailed on the website, as a private investment company, Linnaeus typically caters to private market needs which may include later-stage and growth investments. Geographically located in Europe, it presumably involves investments within the region. The firm does not explicitly disclose total assets under management or individual fund structures.
While the specific portfolio is not detailed in the information provided, Linnaeus Capital Partners is marked by a vision-oriented investment philosophy aimed at fostering growth and development across its investee companies.
Linse Capital
Linse Capital is a growth equity firm based in San Juan, Puerto Rico, founded in 2015 by Michael Linse, a former partner at Kleiner Perkins Caufield & Byers and Goldman Sachs. The firm has a team of seven professionals, including Bastiaan Janmaat as Managing Director and Dario Constantine as Principal. Linse Capital is known for its high-conviction investment strategy, focusing on a select few companies rather than diversifying across many.
The firm invests primarily in deep technology sectors such as transportation, renewable energy, space, and logistics. Linse Capital typically participates in later-stage funding rounds, including Series D, and manages over $1.7 billion in assets. The firm is a Registered Investment Adviser (RIA) and operates with a flexible approach to support companies through various stages of growth and challenges.
Notable investments by Linse Capital include SpaceX - space exploration, ChargePoint - EV charging, Verkada - security, Skydio - autonomous drones, and Impulse Space - space mobility. The firm has also invested in companies like Thea Energy, Waabi, and Lace Lithography, showcasing its commitment to backing transformative technologies.
Linzor Capital Partners
Linzor Capital Partners is a leading pan-regional private equity firm focused on the middle market in Latin America, operating out of four offices in Santiago, Chile; Buenos Aires, Argentina; Mexico City, Mexico; and Bogota, Colombia. Linzor has raised over $1.2 billion of capital commitments since its founding in 2006.
Lion Bird
Lion Bird is a venture capital firm based in Tel Aviv that focuses on healthcare technology. The firm was co-founded by Jonathan Friedman, Gal Noyman Veksler, Assaf Wahrhaft, Ed Michael, Chaim Friedman, and Itschak Friedman. With a strong team composed of individuals with diverse backgrounds in healthcare, technology, and venture capital, the firm brings a unique set of skills to its portfolio companies. Lion Bird distinguishes itself by supporting early-stage startups that aim to reset healthcare’s relationship with technology.
Lion Bird specializes in healthcare services and healthtech, providing pre-scale capital to startups. The firm typically invests in pre-seed, seed, and early-stage companies, offering check sizes ranging from $0-1 million. Lion Bird primarily focuses on North America and Israel, although it is open to global opportunities. The firm is driven by a mission to create long-term relationships with its portfolio companies, offering guidance and insights to navigate the healthtech landscape.
Notable investments by Lion Bird include companies such as NeuroLabs AI - an opioids dependence prevention platform, TriCares - a next-gen patient management system, and iMDsoft - a provider of Clinical Information Systems. These investments showcase Lion Bird's commitment to supporting innovative solutions in the healthcare sector.
Lion Capital LLP
Lion Capital is a consumer-focused investor passionate about investing in brands about which people are passionate. Our Principals have invested over €6 billion in over 100 consumer brands since the late 1990s. Lion’s team draws from its deep investing and operating expertise to identify consumer brands with strong growth potential and implement value creating strategies within these businesses.